A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
Bill Clinton, former President of the United States, has spoken of his first marriage proposal to Hillary Clinton... in the Lake District.
The EFL trophy draw has been made. The 64-team tournament is being trialled, with Premier League sides being invited to field under-21 sides
Officers involved in the shooting of Anthony Grainger may be offered immunity from prosecution based on evidence they give to an Inquiry.